Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | METAP2 | P50579 | 1/20 | 0.30 |
| ▸ | METAP1 | P53582 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3422844 | 0.82 | — | — | |
| SCHEMBL3420184 | 0.80 | — | — | |
| SCHEMBL28449643 | 0.80 | ALDH1A1 (0.38) | ALDH1A1CYP3A4ALOX15TDP1 | |
| SCHEMBL1404280 | 0.75 | ALDH1A1 (0.37) | ALDH1A1CYP3A4ALOX15TDP1 | |
| SCHEMBL13896957 | 0.75 | ALDH1A1 (0.38) | ALDH1A1CYP3A4ALOX15TDP1 | |
| SCHEMBL11032438 | 0.75 | ALDH1A1 (0.40) | ALDH1A1CYP3A4ALOX15TDP1 | |
| SCHEMBL25191603 | 0.74 | — | — | |
| SCHEMBL3419471 | 0.74 | — | — | |
| SCHEMBL23532231 | 0.74 | — | — | |
| SCHEMBL11854217 | 0.73 | ALDH1A1 (0.39) | ALDH1A1CYP3A4ALOX15TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4196564-A1 | CONSUMER PRODUCTS CONTAINING PRO-FRAGRANCES | Firmenich SA (CH) | 2023-06-21 | — | — | EP | claimed |
| EP-2989193-A1 | POUCH COMPRISING A LIQUID DETERGENT COMPOSITION | The Procter & Gamble Company (US) | 2016-03-02 | — | — | EP | claimed |
| WO-2014176392-A1 | POUCH COMPRISING A LIQUID DETERGENT COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2014-10-30 | — | — | WO | claimed |
| WO-2012113746-A1 | CONSUMER PRODUCTS CONTAINING PRO-FRAGRANCES | FIRMENICH SA (CH) | 2012-08-30 | — | — | WO | claimed |
| EP-4370644-A1 | CONSUMER PRODUCTS COMPRISING DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS | The Procter & Gamble Company (US) | 2024-05-22 | — | — | EP | disclosed |
| EP-4369931-A2 | DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS | Encapsys, LLC (US) | 2024-05-22 | — | — | EP | disclosed |
| EP-4196564-A1 | CONSUMER PRODUCTS CONTAINING PRO-FRAGRANCES | Firmenich SA (CH) | 2023-06-21 | — | — | EP | disclosed |
| WO-2023288239-A1 | CONSUMER PRODUCTS COMPRISING DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS | THE PROCTER & GAMBLE COMPANY (US) | 2023-01-19 | — | — | WO | disclosed |
| WO-2023287867-A2 | DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS | ENCAPSYS, LLC (US) | 2023-01-19 | — | — | WO | disclosed |
| CN-113728136-A | Freshening compositions containing alkoxylated phenols | 宝洁公司 | 2021-11-30 | — | — | CN | disclosed |
| CN-107001993-B | Detergent for clothes | 狮王株式会社 | 2020-09-01 | — | — | CN | disclosed |
| US-10738265-B2 | Laundry detergent compositions comprising renewable components | THE PROCTER & GAMBLE COMPANY (US) | 2020-08-11 | — | — | US | disclosed |
| US-7846887-B2 | Cysteine derivatives which counteract malodour | GIVAUDAN SA (CH) | 2010-12-07 | — | — | US | disclosed |
| JP-4552939-B2 | — | 宇部興産株式会社 | 2010-09-29 | — | — | JP | disclosed |
| US-20100179088-A1 | Cysteine Derivatives Which Counteract Malodour | GIVAUDAN SA (CH) | 2010-07-15 | — | — | US | disclosed |
| EP-2167463-A1 | CYSTEINE DERIVATIVES WHICH COUNTERACT MALODOUR | Givaudan SA (CH) | 2010-03-31 | — | — | EP | disclosed |
| EP-2022780-A2 | Cysteine derivatives which counteract malodour | Givaudan SA (CH) | 2009-02-11 | — | — | EP | disclosed |
| WO-2008154765-A1 | CYSTEINE DERIVATIVES WHICH COUNTERACT MALODOUR | GIVAUDAN SA (CH) | 2008-12-24 | — | — | WO | disclosed |
| JP-WO2006013920-A1 | — | 宇部興産株式会社 | 2008-05-01 | — | — | JP | disclosed |
| WO-2006013920-A1 | 2-SUBSTITUTED-3-(4-TETRAHYDROPYRANYL)-3-OXOPROPANOIC ESTER AND PROCESS FOR PRODUCING THE SAME | UBE INDUSTRIES, LTD. (JP) | 2006-02-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100179088-A1 | Cysteine Derivatives Which Counteract Malodour | CBR3, CBR1, GSR | ALDH1A1 199/4885CYP3A4 535/4885ALOX15 1498/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.